Xenodiagnosis After Antibiotic Treatment for Lyme Disease

NCT02446626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-06-03

Study results available
· View outcomes & findings →

Summary

Background:

The most common tick-borne illness in the United States, Lyme disease is caused by Borrelia burgdorferi bacteria that are transmitted to people by Ixodes scapularis ticks. Most cases of Lyme disease are cured by antibiotics, but some patients continue to experience symptoms despite the absence of detectable Lyme bacteria. Xenodiagnosis uses a vector to detect the presence of a disease-causing microbe. Researchers will use live, laboratory-bred ticks to see if Lyme disease bacteria can be detected in people after completing antibiotic therapy and if that is more common in people who continue to experience symptoms such as fatigue and joint pain.

Objectives:

\- To see if ticks can be used to detect B. burgdorferi in people who have had Lyme disease and received antibiotic therapy and if it correlates with persistent symptoms.

Eligibility:

* Adults at least 18 years old who have:
* Untreated erythema migrans (the Lyme disease rash); OR
* Untreated Lyme arthritis; OR
* Continuing symptoms after treatment for Lyme disease; OR
* Had Lyme disease and antibiotic treatment within the past 12 months.
* Healthy volunteers

Design:

* Participants will be screened with medical history, physical exam, and blood tests.
* Visit 1:
* Blood and urine tests, health questionnaire.
* Up to 30 laboratory-bred, pathogen-free, larval ticks (each smaller than a poppy seed) will be placed under a dressing.
* Participants may have two small biopsies of skin .
* 4 6 days later, Visit 2:
* Dressing will be removed and ticks will be collected.
* Participants will answer symptom questions.
* If many ticks are still attached, participants will have to come back the next day. If not enough ticks feed successfully, the procedure may be repeated.
* Participants will keep a diary of symptoms for 30 days. Over 3 months, they will be return to the clinic 3 times to see how they feel and answer questionnaires. Test results will be discussed.

Conditions

  • Lyme Disease

Interventions

PROCEDURE

Skin biopsy

Optional 2-3mm skin punch biopsies will be performed.

PROCEDURE

Blood draw

Peripheral blood draws will be performed.

DEVICE

Xenodiagnosis

Larval ticks will be obtained from Dr. Sam Telford from a laboratory maintained tick colony at Tufts Veterinary School. These ticks are hatched from eggs laid by ticks that have fed only on specific pathogen free laboratory animals that were purchased from established vendors. Between 25-30 larval ticks that have been aged and are known to be ready to attach will be placed on the study participant.

Sponsors & Collaborators

  • Stony Brook University

    collaborator OTHER
  • Mansfield Family Practice LLC

    collaborator OTHER
  • Tufts Medical Center

    collaborator OTHER
  • New York Medical College

    collaborator OTHER
  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Adriana R Marques, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-24
Primary Completion
2022-05-04
Completion
2022-05-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02446626 on ClinicalTrials.gov